Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Optimal test-assisted quarantine strategies for COVID-19

Bo Peng, Wen Zhou, Rowland W. Pettit, Patrick Yu, Peter G. Matos, Alexander L. Greninger, Julie McCashin, View ORCID ProfileChristopher I. Amos
doi: https://doi.org/10.1101/2020.11.06.20222398
Bo Peng
1Institute for Clinical & Translational Research, Baylor College of Medicine, One Baylor Plaza, Suite 100D (MS:451), Houston, Texas, U.S.A., 77030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen Zhou
1Institute for Clinical & Translational Research, Baylor College of Medicine, One Baylor Plaza, Suite 100D (MS:451), Houston, Texas, U.S.A., 77030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rowland W. Pettit
1Institute for Clinical & Translational Research, Baylor College of Medicine, One Baylor Plaza, Suite 100D (MS:451), Houston, Texas, U.S.A., 77030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Yu
2Corporate Medical Advisors, 1600 Smith St., Suite 4900, Houston, TX, U.S.A., 77002
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter G. Matos
2Corporate Medical Advisors, 1600 Smith St., Suite 4900, Houston, TX, U.S.A., 77002
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander L. Greninger
3Department of Laboratory Medicine, University of Washington, Box 357110, 1959 NE Pacific Street, NW120, Seattle, WA, U.S.A., 98195k
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie McCashin
4International S.O.S., 1600 Smith Street, Suite 4900, Houston TX, U.S.A., 77002
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher I. Amos
1Institute for Clinical & Translational Research, Baylor College of Medicine, One Baylor Plaza, Suite 100D (MS:451), Houston, Texas, U.S.A., 77030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher I. Amos
  • For correspondence: chrisa@bcm.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To evaluate the effectiveness of SARS-CoV-2 testing on shortening the duration of quarantines for COVID-19 and to identify the most effective choices of testing schedules.

Design We performed extensive simulations to evaluate the performance of quarantine strategies when one or more SARS-CoV-2 tests were administered during the quarantine. Simulations were based on statistical models for the transmissibility and viral loads of SARS-CoV-2 infections and the sensitivities of available testing methods. Sensitivity analyses were performed to evaluate the impact of perturbations in model assumptions on the outcomes of optimal strategies.

Results We found that SARS-CoV-2 testing can effectively reduce the length of a quarantine without compromising safety. A single RT-PCR test performed before the end of quarantine can reduce quarantine duration to 10 days. Two tests can reduce the duration to 8 days, and three highly sensitive RT-PCR tests can justify a 6-day quarantine. More strategic testing schedules and longer quarantines are needed if tests are administered with less sensitive RT-PCR tests or antigen tests. Shorter quarantines can be utilized for applications that tolerate a residual post-quarantine transmission risk comparable to a 10-day quarantine.

Conclusions Testing could substantially reduce the length of isolation, reducing the physical and mental stress caused by lengthy quarantines. With increasing capacity and lowered costs of SARS-CoV-2 tests, test-assisted quarantines could be safer and more cost-effective than 14-day quarantines and warrant more widespread use.

What is already known on this topic?

  • Recommendations for quarantining individuals who could have been infected with COVID-19 are based on limited evidence.

  • Despite recent theoretical and case studies of test-assisted quarantines, there has been no substantive investigation to quantify the safety and efficacy of, nor an exhaustive search for, optimal test-assisted quarantine strategies.

What this study adds

  • Our simulations indicate that the 14-day quarantine approach is overly conservative and can be safely shortened if testing is performed.

  • Our recommendations include testing schedules that could be immediately adopted and implemented as government and industry policies.

Role of the Funding Source A major technology company asked that we perform simulations to understand the optimal strategy for managing personnel quarantining before forming cohorts of individuals who would work closely together. The funding entity did not influence the scope or output of the study but requested that we include antigen testing as a component of the quarantining process. Patrick Yu and Peter Matos are employees of Corporate Medical Advisors, and International S.O.S employs Julie McCashin. Other funding sources are research grants and did not influence the investigation.

Competing Interest Statement

JM is an employee of International SOS. BP and PM are consultants to International SOS.

Funding Statement

The authors appreciate financial support from a major technology client, for whom simulations were initially developed.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not Applicable.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Ethical Considerations & Disclosures: None

  • As suggested by reviewers, we have added optimal test-assisted quarantine strategies for more RT-PCR and Antigen tests with lower clinical sensitivities, and more discussions on impact of viral load and incubation periods.

Data Availability

The simulation program (covid19-outbreak-simulator), that is used for all simulations for this study is publicly available at https://github.com/ictr/covid19-outbreak-simulator under a BSD 3-clause license. All simulated scenarios and their results will be made available in the Applications section of the homepage of the simulator.

https://github.com/ictr/covid19-outbreak-simulator

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 22, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Optimal test-assisted quarantine strategies for COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Optimal test-assisted quarantine strategies for COVID-19
Bo Peng, Wen Zhou, Rowland W. Pettit, Patrick Yu, Peter G. Matos, Alexander L. Greninger, Julie McCashin, Christopher I. Amos
medRxiv 2020.11.06.20222398; doi: https://doi.org/10.1101/2020.11.06.20222398
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Optimal test-assisted quarantine strategies for COVID-19
Bo Peng, Wen Zhou, Rowland W. Pettit, Patrick Yu, Peter G. Matos, Alexander L. Greninger, Julie McCashin, Christopher I. Amos
medRxiv 2020.11.06.20222398; doi: https://doi.org/10.1101/2020.11.06.20222398

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Systems and Quality Improvement
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (940)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8967)
  • Forensic Medicine (4)
  • Gastroenterology (417)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1320)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10764)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1815)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4107)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (361)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)